Stock Performance

Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment

Inhibrx stock

Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment

San Diego, CA – October 24, 2025 – Inhibrx (NASDAQ: INBX) shares have surged dramatically, skyrocketing over 70% in pre-market and after-hours trading, following the announcement of overwhelmingly positive topline results from its registrational trial of ozekibart (INBRX-109) for advanced or metastatic, unresectable chondrosarcoma. This monumental achievement positions ozekibart as a potential

By MarketMinute
Fastenal (FAST) Shares Plunge After Q3 Miss: Industrial Supplier Fails to Meet Elevated Expectations Amidst Manufacturing Headwinds

Fastenal

Fastenal (FAST) Shares Plunge After Q3 Miss: Industrial Supplier Fails to Meet Elevated Expectations Amidst Manufacturing Headwinds

Fastenal (NASDAQ: FAST) found itself in the spotlight as a bottom performer on October 13, 2025, with its shares experiencing a notable decline following the release of its third-quarter 2025 financial results. Despite reporting year-over-year growth in both earnings and revenue, the industrial supply giant fell short of Wall Street&

By MarketMinute
SolarEdge Shines: Analyst Upgrades Ignite Stock Performance as Solar Sector Eyes Revival

SolarEdge Technologies

SolarEdge Shines: Analyst Upgrades Ignite Stock Performance as Solar Sector Eyes Revival

In a powerful demonstration of how institutional endorsements can reshape market perceptions, shares of SolarEdge Technologies (NASDAQ: SEDG) have experienced a notable ascent, propelled by a series of optimistic analyst upgrades. These positive revisions from prominent financial institutions have not only injected fresh momentum into the solar energy company'

By MarketMinute